0
Your cart

Your cart is empty

Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries

Buy Now

Redefining Innovation - Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry (Paperback) Loot Price: R1,017
Discovery Miles 10 170
Redefining Innovation - Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry (Paperback): Ruchin Kansal,...

Redefining Innovation - Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry (Paperback)

Ruchin Kansal, Jeff Huth

 (sign in to rate)
Loot Price R1,017 Discovery Miles 10 170 | Repayment Terms: R95 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Most people marvel at the level of innovation demonstrated by the biopharmaceutical industry in bringing new products to the market - especially in the past 20 years. However, there is a crisis looming in the industry that should be a concern to all of us who take for granted the constant pace at which new treatments, and increasingly cures, have emerged from the laboratories of current sector incumbents. In the book, we examine the evolution of the biopharmaceutical industry to understand how it became what we term a "unicorn industry" with a unique, US-centered business model that has led to multiple blockbuster products (aka, unicorns) year after year. We explore how past success has created perceived barriers to innovation diversification beyond the chemical or biological-based biopharmaceutical product, and highlight the warning signs of the industry's decline. We define a potential pathway for transforming the industry's business model by broadening the definition, sources, and enablers of innovation beyond the traditional biopharmaceutical product. We introduce and advocate for the 80-80 Rule - "Being 80% confident that you will only be 80% right the first time should feel normal." The 80-80 Rule is a theme that emphasizes speed and willingness to embrace uncertainty and overcome internal barriers to change. It sets the standard for redefining innovation as a platform to reignite growth of the biopharmaceutical industry.

General

Imprint: Taylor & Francis
Country of origin: United Kingdom
Release date: September 2021
First published: 2018
Authors: Ruchin Kansal • Jeff Huth
Dimensions: 234 x 156mm (L x W)
Format: Paperback
Pages: 228
ISBN-13: 978-1-03-217870-7
Categories: Books > Business & Economics > Business & management > Business strategy
Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries
LSN: 1-03-217870-1
Barcode: 9781032178707

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners